Industry Statistics and Trends
Market size and recent performance (2014-2029)
Industry revenue has grown at a CAGR of 5.9 % over the past five years, to reach an estimated $8.9bn in 2024.
Trends and Insights
Outsourcing becomes the status quo in drug development
- The pharmaceutical industry has increasingly been outsourcing activities in recent years. A combination of factors is behind this trend, including the need for cost savings, access to specialized expertise and adaptable staffing models.
- Additional trends and insights available with purchase
Source: Alfabank-Adres
Industry outlook (2024-2029)
Market size is projected to grow over the next five years.
Trends and Insights
An evolving pharmaceutical landscape will make outsourcing more valuable
- Functional service providers (FSPs), including clinical trial data management (CDM) companies, will become more embedded in clinical drug development in the future. A mix of cost, regulatory, technical and competitive pressures will encourage this trend.
Biggest companies in the Clinical Trial Data Management Services in the US
| Company | Market Share (%)
2024 | Revenue ($short_0)
2024 | Profit ($short_0)
2024 | Profit Margin (%)
2024 |
|---|
There are no companies that hold a large enough market share in the Clinical Trial Data Management Services in the US industry for Alfabank-Adres to include in this product.
Products & Services Segmentation
Source: Alfabank-Adres
Industry revenue is measured across several distinct product and services lines, including Oncology trials, Rare disease trials and Immunology trials. Oncology trials is the largest segment of the Clinical Trial Data Management Services in the US.
Trends and Insights
Industry services can be broken down by delivery method
- CTMS services are generally disaggregated into delivery methods and industry revenue is divided between online-based, cloud-based and on-premise CTMS services. The primary difference exists between online- and cloud-based services and on-premise services.
- More insights available in the full report
Table of Contents
About this industry
Industry definition
Clinical trial data management providers specialize in collecting, processing and storing data generated during clinical trials. Their primary role is to ensure that data from these trials is accurate, consistent, secure and complies with regulatory standards.
What's included in this industry?
Providing clinical trial data management for oncology trialsProviding clinical trial data management for rare disease trialsProviding clinical trial data management for immunology trialsProviding clinical trial data management for neuroscience trialsProviding clinical trial data management for cardiovascular trialsProviding clinical trial data management for infectious disease trialsCompanies
Purchase this report to view all major companies in this industry.
Related Terms
CLINICAL TRIALPHARMACEUTICALBIOPHARMACEUTICALSPONSORPARTICIPANTIndustry Code
NAICS 51821 - Clinical Trial Data Management Services in the US
Performance
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Analyst insights
Purchase this report to unlock analyst insights.
In this chapter (4)
- Current Performance
- Outlook
- Volatility
- Life Cycle
Key metrics
- Annual Revenue, Recent Growth, Forecast, Revenue Volatility
- Number of Employees, Recent Growth, Forecast, Employees per Business, Revenue per Employee
- Number of Businesses, Recent Growth, Forecast, Employees per Business, Revenue per Business
- Total Profit, Profit Margin, Profit per Business
Charts
- Revenue, including historical (2014-2023) and forecast (2024-2029)
- Employees, including historical (2014-2023) and forecast (2024-2029)
- Businesses, including historical (2014-2023) and forecast (2024-2029)
- Profit, including historical (2014-2024)
- Industry Volatility vs. Revenue Growth
- Industry Life Cycle
Detailed analysis
- Trends in supply, demand and current events that are driving current industry performance
- Expected trends, economic factors and ongoing events that drive the industry's outlook
- Key success factors for businesses to overcome volatility
- How contribution to GDP, industry saturation, innovation, consolidation, and technology and systems influence the industry's life cycle phase.
Products and Markets
Learn about an industry's products and services, markets and trends in international trade.
Analyst insight
Biotechnology companies access valuable resources through outsourcing. Smaller biotech firms are increasingly outsourcing labor-intensive data management to gain access to sp...
In this chapter
- Products & Services
- Major Markets
Key metrics
- Largest market segment and value in 2024
- Product innovation level
Charts
- Products & services segmentation in 2024
- Major market segmentation in 2024
Detailed analysis
- Trends impacting the recent performance of the industry's various segments
- Innovations in the industry's product or service offering, specialization or delivery method
- Key factors that successful businesses consider in their offerings
- Buying segments and key trends influencing demand for industry products and services
Geographic Breakdown
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
Analyst insights
Regions with active pharma and biotechnology hubs benefit clinical trial data management providers. Areas like the Mid-Atlantic offer access to a skilled workforce, research ...
In this chapter (1)
- Business Locations
Charts
- Share of revenue, establishment, wages and employment in each state
- Share of population compared to establishments in each region in 2024
Tables
- Number and share of establishments in each state in 2024
- Number and share of revenue each state accounts for in 2024
- Number and share of wages each state accounts for in 2024
- Number and share of employees in each state in 2024
Detailed analysis
- Geographic spread of the industry across North America, and trends associated with changes in the business landscape
- Key success factors for businesses to use location to their advantage
Competitive Forces
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Analyst insights
Clinical trial sponsors outsource to companies that mitigate risks. Sponsors outsource to reputable companies with track records of handling complex trials to support their t...
In this chapter (4)
- Concentration
- Barriers to Entry
- Substitutes
- Buyer & Supplier Analysis
Key metrics
- Industry concentration level
- Industry competition level and trend
- Barriers to entry level and trend
- Substitutes level and trend
- Buyer power level and trend
- Supplier power level and trend
Charts
- Market share concentration among the top 4 suppliers from 2019-2024
- Supply chain including upstream supplying industries and downstream buying industries, flow chart
Detailed analysis
- Factors impacting the industry’s level of concentration, such as business distribution, new entrants, or merger and acquisition activity.
- Key success factors for businesses to manage the competitive environment of the industry.
- Challenges that potential industry entrants face such as legal, start-up costs, differentiation, labor/capital intensity and capital expenses.
- Key success factors for potential entrants to overcome barriers to entry.
- Competitive threats from potential substitutes for the industry’s own products and services.
- Key success factors for how successful businesses can compete with substitutes.
- Advantages that buyers have to keep favorable purchasing conditions.
- Advantages that suppliers have to maintain favorable selling conditions.
- Key success factors for how businesses can navigate buyer and supplier power.
Companies
Learn about the performance of the top companies in the industry.
Analyst insights
Clinical trial data management providers operate in a competitive and diverse landscape. Clinical trials require highly specialized and tailored data management, which smalle...
In this chapter
- Market Share Concentration
- Companies
- Company Spotlights
Charts
- Industry market share by company in 2020 through 2024
- Major companies in the industry, including market share, revenue, profit and profit margin in 2024
Detailed analysis
External Environment
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Analyst insights
A shift in pharmaceutical development enhances outsourcing’s role. Drug development increasingly focuses on personalized, tailored medicine, which requires more complex, intr...
In this chapter
- External Drivers
- Regulation & Policy
- Assistance
Key metrics
- Regulation & policy level and trend
- Assistance level and trend
Charts
- Regulation & Policy historical data and forecast (2014-2029)
- Assistance historical data and forecast (2014-2029)
Detailed analysis
- Demographic and macroeconomic factors influencing the industry, including Regulation & Policy and Assistance
- Major types of regulations, regulatory bodies, industry standards or specific regulations impacting requirements for industry operators
- Key governmental and non-governmental groups or policies that may provide some relief for industry operators.
Financial Benchmarks
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Analyst insights
Clinical trial data management providers depend on attracting and retaining the best talent to maintain a competitive advantage. Securing top talent in areas like data analyt...
In this chapter
- Cost Structure
- Financial Ratios
- Key Ratios
Key metrics
- Profit margin, and how it compares to the sector-wide margin
- Average wages, and how it compares to the sector-wide average wage
- Largest cost component as a percentage of revenue
- Industry average ratios for days' receivables, industry coverage and debt-to-net-worth ratio
Charts
- Average industry operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Average sector operating costs as a share of revenue, including purchases, wages, depreciation, utilities, rent, other costs and profit in 2024
- Investment vs. share of economy
Data tables
- Industry Multiples (2017-2022)
- Industry Tax Structure (2017-2022)
- Income Statement (2017-2022)
- Balance Sheet (2017-2022)
- Liquidity Ratios (2017-2022)
- Coverage Ratios (2017-2022)
- Leverage Ratios (2017-2022)
- Operating Ratios (2017-2022)
- Cash Flow & Debt Service Ratios (2014-2029)
- Revenue per Employee (2014-2029)
- Revenue per Enterprise (2014-2029)
- Employees per Establishment (2014-2029)
- Employees per Enterprise (2014-2029)
- Average Wage (2014-2029)
- Wages/Revenue (2014-2029)
- Establishments per Enterprise (2014-2029)
- IVA/Revenue (2014-2029)
- Imports/Demand (2014-2029)
- Exports/Revenue (2014-2029)
Detailed analysis
- Trends in the cost component for industry operators and their impact on industry costs and profitability
Key Statistics
Industry Data
Data Tables
Including values and annual change:
- Revenue (2014-2029)
- IVA (2014-2029)
- Establishments (2014-2029)
- Enterprises (2014-2029)
- Employment (2014-2029)
- Exports (2014-2029)
- Imports (2014-2029)
- Wages (2014-2029)
Top Questions Answered
Unlock comprehensive answers and precise data upon purchase. View purchase options.
What is the market size of the Clinical Trial Data Management Services in the US industry in United States in 2024?
The market size of the Clinical Trial Data Management Services in the US industry in United States is $8.9bn in 2024.
How many businesses are there in the Clinical Trial Data Management Services in the US industry in 2024?
There are 1,805 businesses in the Clinical Trial Data Management Services in the US industry in United States, which has grown at a CAGR of 7.2 % between 2019 and 2024.
Has the Clinical Trial Data Management Services in the US industry in United States grown or declined over the past 5 years?
The market size of the Clinical Trial Data Management Services in the US industry in United States has been growing at a CAGR of 5.9 % between 2019 and 2024.
What is the forecast growth of the Clinical Trial Data Management Services in the US industry in United States over the next 5 years?
Over the next five years, the Clinical Trial Data Management Services in the US industry in United States is expected to grow.
What does the Clinical Trial Data Management Services in the US in United States include?
Providing clinical trial data management for oncology trials and Providing clinical trial data management for rare disease trials are part of the Clinical Trial Data Management Services in the US industry.
How competitive is the Clinical Trial Data Management Services in the US industry in United States?
The level of competition is moderate and steady in the Clinical Trial Data Management Services in the US industry in United States.
Related Industries
Widen your competitive advantage with related industries
Competitors
- Contract Research Organizations in the US
Complementors
- Brand Name Pharmaceutical Manufacturing in the US
- Diagnostic & Medical Laboratories in the US
- Generic Pharmaceutical Manufacturing in the US
- Biotechnology in the US
- Animal Health Biotechnology in the US
- Cell Therapy in the US
International industries
- Global Biotechnology
- Brand-Name Pharmaceutical Manufacturing in Canada
- Generic Pharmaceutical Manufacturing in Canada
- Pharmaceutical Preparations Manufacturing in the UK
View all industries in United States
Methodology
How are Alfabank-Adres reports created?
Alfabank-Adres has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for Alfabank-Adres readers. Finally, each report is reviewed by one of Alfabank-Adres’s editors, who provide quality assurance to ensure accuracy and readability.
Alfabank-Adres relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
What data sources do Alfabank-Adres analysts use?
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the US include:
- US Census Bureau
- US Bureau of Labor Statistics
- US International Trade Commission
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
- Industry and trade associations
- Industry federations or regulators
- Major industry players annual or quarterly filings
Finally, Alfabank-Adres’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
How does Alfabank-Adres forecast its data?
Alfabank-Adres’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
Alfabank-Adres prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
